Magnetar Financial LLC Makes New Investment in Humana Inc. (NYSE:HUM)

Magnetar Financial LLC bought a new position in Humana Inc. (NYSE:HUM) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 59,937 shares of the insurance provider’s stock, valued at approximately $15,207,000.

Several other hedge funds have also added to or reduced their stakes in HUM. Pzena Investment Management LLC boosted its holdings in Humana by 44.0% in the fourth quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider’s stock worth $915,736,000 after acquiring an additional 1,103,132 shares in the last quarter. Boston Partners raised its stake in shares of Humana by 435.8% in the fourth quarter. Boston Partners now owns 1,098,702 shares of the insurance provider’s stock worth $279,236,000 after purchasing an additional 893,637 shares during the last quarter. FMR LLC raised its stake in shares of Humana by 23.4% in the third quarter. FMR LLC now owns 3,388,859 shares of the insurance provider’s stock worth $1,073,387,000 after purchasing an additional 643,291 shares during the last quarter. Retirement Systems of Alabama raised its stake in shares of Humana by 735.9% in the fourth quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider’s stock worth $55,563,000 after purchasing an additional 192,801 shares during the last quarter. Finally, Worldquant Millennium Advisors LLC purchased a new position in shares of Humana in the third quarter worth $50,102,000. 92.38% of the stock is owned by institutional investors.

Insider Transactions at Humana

In other news, insider Timothy S. Huval sold 3,703 shares of the company’s stock in a transaction dated Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the transaction, the insider now owns 8,181 shares of the company’s stock, valued at $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 0.37% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on HUM shares. Truist Financial boosted their price target on Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a research note on Monday, January 6th. Barclays boosted their price target on Humana from $255.00 to $270.00 and gave the stock an “equal weight” rating in a research note on Thursday, February 13th. JPMorgan Chase & Co. decreased their price target on Humana from $257.00 to $256.00 and set a “neutral” rating for the company in a research note on Tuesday, February 18th. Piper Sandler boosted their price target on Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a research note on Wednesday, January 15th. Finally, StockNews.com cut Humana from a “buy” rating to a “hold” rating in a research report on Tuesday. Nineteen research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $285.68.

Humana Stock Performance

NYSE HUM opened at $267.01 on Thursday. The firm has a market cap of $32.23 billion, a price-to-earnings ratio of 26.84, a price-to-earnings-growth ratio of 2.05 and a beta of 0.57. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. The business has a 50-day moving average price of $271.43 and a 200-day moving average price of $278.21. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $406.46.

Humana (NYSE:HUM) last released its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, topping analysts’ consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. As a group, equities research analysts predict that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.33%. The ex-dividend date is Friday, March 28th. Humana’s dividend payout ratio (DPR) is 35.58%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.